Literature DB >> 12133808

The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development .

Irwin H Gelman1.   

Abstract

Scaffolding proteins are thought to facilitate the efficiency and specificity of enzyme/substrate reactions by coordinating their interaction along a cytoskeletal infrastructure in a spacial and temporal manner. Rodent SSeCKS, and its human orthologue, Gravin, seem to function as tumor suppressors and regulators of mitogenesis, inflammatory response, development and differentiation via novel scaffolding functions involving the selective binding of key G1-->S phase signaling proteins such as protein kinase C (PKC), PKA, calmodulin, cyclins and beta-adrenergic receptors. The association of SSeCKS/Gravin with the actin-based cytoskeleton as well as to plasma membrane sites via N-terminal myristylation places these proteins at the junction of signaling and cytoskeletal pathways. The following review describes the regulatory and scaffolding functions of SSeCKS and Gravin and how mitogen-induced phosphorylation modulates their ability to regulate cell adhesion, signaling, mitogenesis and oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12133808     DOI: 10.2741/A879

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  35 in total

1.  Role of src-suppressed C kinase substrate in rat pulmonary microvascular endothelial hyperpermeability stimulated by inflammatory cytokines.

Authors:  Qing-Hai You; Geng-Yun Sun; Nan Wang; Shan Chen; Qing-Li Luo
Journal:  Inflamm Res       Date:  2010-05-08       Impact factor: 4.575

Review 2.  AKAPs (A-kinase anchoring proteins) and molecules that compose their G-protein-coupled receptor signalling complexes.

Authors:  Craig C Malbon; Jiangchuan Tao; Hsien-yu Wang
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

Review 3.  A-kinase anchoring proteins as potential drug targets.

Authors:  Jessica Tröger; Marie C Moutty; Philipp Skroblin; Enno Klussmann
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 4.  Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12.

Authors:  Irwin H Gelman
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

5.  SSeCKS promote beta-amyloid-induced PC12 cells neurotoxicity by up-regulating tau phosphorylation in Alzheimer's disease.

Authors:  Zhiming Cui; Tao Tao; Chun Cheng; Junling Yang; Qin Shen; Yuhong Ji; Xiaohong Li; Haiou Liu; Aiguo Shen; Xiang Lu
Journal:  Mol Cell Biochem       Date:  2010-03-16       Impact factor: 3.396

6.  A-Kinase Anchor Protein 12 Is Required for Oligodendrocyte Differentiation in Adult White Matter.

Authors:  Takakuni Maki; Yoon Kyung Choi; Nobukazu Miyamoto; Akihiro Shindo; Anna C Liang; Bum Ju Ahn; Emiri T Mandeville; Seiji Kaji; Kanako Itoh; Ji Hae Seo; Irwin H Gelman; Josephine Lok; Ryosuke Takahashi; Kyu-Won Kim; Eng H Lo; Ken Arai
Journal:  Stem Cells       Date:  2018-01-22       Impact factor: 6.277

7.  Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12.

Authors:  Shin Akakura; Peter Nochajski; Lingqiu Gao; Paula Sotomayor; Sei-ichi Matsui; Irwin H Gelman
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

8.  Gravin dynamics regulates the subcellular distribution of PKA.

Authors:  Xiaohong Yan; Magdalena Walkiewicz; Jennifer Carlson; Laura Leiphon; Bryon Grove
Journal:  Exp Cell Res       Date:  2009-01-13       Impact factor: 3.905

9.  Receptor-mediated Ca2+ and PKC signaling triggers the loss of cortical PKA compartmentalization through the redistribution of gravin.

Authors:  Micah B Schott; Bryon Grove
Journal:  Cell Signal       Date:  2013-07-06       Impact factor: 4.315

10.  SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway.

Authors:  Bing Su; Yahao Bu; David Engelberg; Irwin H Gelman
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.